Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Mirvie
company
About
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $45M
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe.It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$45M
Mirvie has raised a total of
$45M
in funding over 2 rounds. Their latest funding was raised on
May 17, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 17, 2022 | Series B | $45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Mirvie is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
General Catalyst
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
